Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats

Indian Journal of Pharmacology

Volumn 46, Issue 6, 2014, Pages 627-632

  Maheshwari, Rajesh A ^a   Balaraman, R ^a   Sen, Ashim K ^a   Seth, A K ^a  

^a K M SHAH DENTAL COLLEGE AND HOSPITAL   (India)

Author keywords

Coenzyme Q10; diabetic nephropathy; metformin; transforming growth factor ; tumor necrosis factor

Indexed keywords

CATALASE; CREATININE; GLUTATHIONE; HEMOGLOBIN A1C; MALONALDEHYDE; METFORMIN; MYELOPEROXIDASE; NICOTINAMIDE; NITRITE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UBIDECARENONE; UREA; URIC ACID; ANTIDIABETIC AGENT; HEMOGLOBIN; PEROXIDASE; PROTECTIVE AGENT; TUMOR NECROSIS FACTOR; UBIQUINONE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES CONTROL; DIABETIC NEPHROPATHY; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; KIDNEY INJURY; KIDNEY MASS; KIDNEY PARENCHYMA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UREA BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; COMBINATION DRUG THERAPY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG EFFECTS; FEMALE; KIDNEY; MALE; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG THERAPY, COMBINATION; FEMALE; HEMOGLOBINS; HYPOGLYCEMIC AGENTS; KIDNEY; MALE; METFORMIN; NIACINAMIDE; NITRITES; PEROXIDASE; PROTECTIVE AGENTS; RATS, WISTAR; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; UBIQUINONE; UREA; URIC ACID;

EID: 84916208765     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.144924     Document Type: Article

References (33)

1. Yan HD, Li XZ, Xie JM, Li M. Effects of advanced glycation end products on renal fi brosis and oxidative stress in cultured NRK-49F cells. Chin Med J (Engl) 2007; 120: 787-93
2. Barnett A. Prevention of loss of renal function over time in patients with diabetic nephropathy. Am J Med 2006; 119: S40-7
3. Lee SH, Heo SJ, Hwang JY, Han JS, Jeon YJ. Protective effects of enzymatic digest from Ecklonia cava against high glucose-induced oxidative stress in human umbilical vein endothelial cells. J Sci Food Agric 2010; 90: 349-56
4. Aljofan M, Ding H. High glucose increases expression of cyclooxygenase-2, increases oxidative stress and decreases the generation of nitric oxide in mouse microvessel endothelial cells. J Cell Physiol 2010; 222: 669-75
5. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 1999; 48: 1-9
6. Bos H, Andersen S, Rossing P, De Zeeuw D, Parving HH, De Jong PE, et al. Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy. Kidney Int Suppl 2000; 75: S32-7
7. Makni M, Sefi M, Fetoui H, Garoui el M, Gargouri NK, Boudawara T, et al. Flax and Pumpkin seeds mixture ameliorates diabetic nephropathy in rats. Food Chem Toxicol 2010; 48: 2407-12
8. Punithavathi VR, Prince PS, Kumar R, Selvakumari J. Antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic Wistar rats. Eur J Pharmacol 2011; 650: 465-71
9. Kamei M, Fujita T, Kanbe T, Sasaki K, Oshiba K, Otani S, et al. The distribution and content of ubiquinone in foods. Int J Vitam Nutr Res 1986; 56: 57-63
10. Schmelzer C, Lindner I, Rimbach G, Niklowitz P, Menke T, Döring F. Functions of coenzyme Q10 in infl ammation and gene expression. Biofactors 2008; 32: 179-83
11. Kohli Y, Suto Y, Kodama T. Effect of hypoxia on acetic acid ulcer of the stomach in rats with or without coenzyme Q10. Jpn J Exp Med 1981; 51: 105-8
12. Lenaz G, Fato R, Formiggini G, Genova ML. The role of coenzyme Q10 in mitochondrial electron transport. Mitochondrion 2007; 7 Suppl: S8-33
13. Alhaider AA, Korashy HM, Sayed-Ahmed MM, Mobark M, Kfoury H, Mansour MA. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression. Chem Biol Interact 2011; 192: 233-42
14. Kamble HV, Bodhankar SL. Trigonelline and sitagliptin attenuates nicotinamide-streptozotocin induced diabetic nephropathy in Wistar rats. Int J Pharm Pharm Sci 2013; 5: 583-9
15. Maheshwari RA, Khatri K, Sailor GU, Balaraman R. Antidiabetic activity of Dibolin (a polyherbal formulation) in streptozotocin-nicotinamide induced type 2 diabetic rats. Int J Pharm Pharm Sci 2014; 2: 893-7
16. Garjani A, Andalib S, Biabani S, Soraya H, Doustar Y, Garjani A, et al. Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat. Eur J Pharmacol 2011; 666: 135-41
17. Waisundara VY, Hsu A, Tan BK, Huang D. Baicalin reduces mitochondrial damage in streptozotocin-induced diabetic Wistar rats. Diabetes Metab Res Rev 2009; 25: 671-7
18. Slater TF, Sawyer BC. The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. General features of the systems used. Biochem J 1971; 123: 805-14
19. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972; 247: 3170-5
20. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-6
21. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-Transferase activities in rat lung and liver. Biochim Biophys Acta 1979; 582: 67-78
22. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal infl ammation based on myeloperoxidase activity. Assessment of infl ammation in rat and hamster models. Gastroenterology 1984; 87: 1344-50
23. Guevara I, Iwanejko J, Dembinska-Kiec A, Pankiewicz J, Wanat A, Anna P, et al. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta 1998; 274: 177-88
24. Ntemka A, Iliadis F, Papanikolaou N, Grekas D. Network-centric analysis of genetic predisposition in diabetic nephropathy. Hippokratia 2011; 15: 232-7
25. Idonije BO, Festus O, Oluba OM. Plasma glucose, creatinine and urea levels in type 2 diabetic patient attending a Nigerian Teaching Hospital. Res J Med Sci 2011; 5: 1-3
26. Ahmadvand H. Effects of coenzyme Q10 on hemoglobin A1C, serum urea and creatinine in alloxan-induced Type 1 diabetic rats. Iran J Pharmacol Ther 2012; 11: 64-7
27. Morales AI, Detaille D, Prieto M, Puente A, Briones E, Arévalo M, et al. Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway. Kidney Int 2010; 77: 861-9
28. Ahmadvand H, Tavafi M, Khosrowbeygi A. Amelioration of altered antioxidant enzymes activity and glomerulosclerosis by coenzyme Q10 in alloxan-induced diabetic rats. J Diabetes Complications 2012; 26: 476-82
29. Maheshwari RA, Sailor GU, Patel L, Balaraman R. Amelioration of cisplatin-induced nephrotoxicity by statins. Indian J Pharmacol 2013; 45: 354-8
30. Cornejo-Garcia JA, Mayorga C, Torres MJ, Fernandez TD, R-Pena R, Bravo I, et al. Anti-oxidant enzyme activities and expression and oxidative damage in patients with non-immediate reactions to drugs. Clin Exp Immunol 2006; 145: 287-95
31. David S, Peter M. Understanding Diabetic Nephropathy-Is There a Genetic Susceptibility? Eur Endocrinol 2008; 4: 66-9
32. Kettle AJ, van Dalen CJ, Winterbourn CC. Peroxynitrite and myeloperoxidase leave the same footprint in protein nitration. Redox Rep 1997; 3: 257-8
33. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-Activated forms. Science 1992; 258: 1898-902